Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 242-980-4 | CAS number: 19351-18-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Experimental start date: 18 July 2017 Experimental completion date: 11 September 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- 2,2-dimethylthiazolidine
- EC Number:
- 242-980-4
- EC Name:
- 2,2-dimethylthiazolidine
- Cas Number:
- 19351-18-9
- Molecular formula:
- C5H11NS
- IUPAC Name:
- 2,2-dimethylthiazolidine
- Test material form:
- liquid
Constituent 1
- Specific details on test material used for the study:
- Physical state/Appearance: Liquid
Expiry Date: 21 September 2017
Storage Conditions: At room temperature
Method
- Target gene:
- histidine locus
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Metabolic activation:
- with and without
- Metabolic activation system:
- Phenobarbital/B-naphthoflavone induced rat liver S9
- Test concentrations with justification for top dose:
- In the pre-experiment the concentration range of the test item was 3 – 5000 µg/plate. The pre-experiment is reported as experiment I. Since no relevant toxic effects were observed 5000 µg/plate were chosen as maximal concentration.
The concentration range included two logarithmic decades. The following concentrations were tested in experiment II:
33; 100; 333; 1000; 2500; and 5000 µg/plate - Vehicle / solvent:
- DMSO (purity > 99 %). The solvent was chosen because of its solubility properties and its relative nontoxicity to the bacteria.
Controlsopen allclose all
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- 10 µg/plate for TA1535 and TA100
- Positive control substance:
- sodium azide
- Remarks:
- Absence of S9-mix
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- 10 µg/plate for TA98, 50 µg/plate for TA1537
- Positive control substance:
- other: 4-nitro-o-phenylene-diamine
- Remarks:
- Absence of S9-mix
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- 2.0 µg/plate for TA102
- Positive control substance:
- other: methyl methane sulfonate
- Remarks:
- Absence of S9-mix
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- 2.5 µg/plate (10.0 µg/plate for TA102)
- Positive control substance:
- other: 2-Aminoanthracene
- Remarks:
- Presence of S9-mix
- Details on test system and experimental conditions:
- Test Item Preparation
All formulations were prepared freshly before treatment and used within two hours of preparation. The formulation was proven to be stable for this period based on Envigo Ref No. FC38CM.
Experimental Design and Study Conduct
Pre-Experiment for Toxicity
To evaluate the toxicity of the test item a pre-experiment was performed with all strains used. Eight concentrations were tested for toxicity and mutation induction with each 3 plates. The experimental conditions in this pre-experiment were the same as described for the experiment I below (plate incorporation test).
Toxicity of the test item can be evident as a reduction in the number of spontaneous revertants or a clearing of the bacterial background lawn.
The pre-experiment is reported as main experiment I, since the following criteria are met:
Evaluable plates (>0 colonies) at five concentrations or more in all strains used.
Experimental Performance
For each strain and dose level, including the controls, three plates were used.
Experiment I (Plate Incorporation)
The following materials were mixed in a test tube and poured onto the selective agar plates:
100 µL Test solution at each dose level (solvent or reference mutagen solution (positive control)),
500 µL S9 mix (for test with metabolic activation) or S9 mix substitution buffer (for test without metabolic activation),
100 µL Bacteria suspension (cf. test system, pre-culture of the strains),
2000 µL Overlay agar
Experiment II (Pre-Incubation)
In the pre-incubation assay 100 µL test solution (solvent or reference mutagen solution (positive control)), 500 µL S9 mix / S9 mix substitution buffer and 100 µL bacterial suspension were mixed in a test tube and incubated at 37 °C for 60 minutes. After pre-incubation 2.0 mL overlay agar (45 °C) was added to each tube. The mixture was poured on minimal agar plates.
After solidification the plates were incubated upside down for at least 48 hours at 37 °C in the dark.
In parallel to each test a sterile control of the test item was performed and documented in the raw data. Therefore, 100 µL of the stock solution, 500 µl S9 mix / S9 mix substitution buffer were mixed with 2.0 mL overlay agar and poured on minimal agar plates.
Data Recording
The colonies were counted using a validated computer system (cf. 3.8, Major computerized systems), which was connected to a PC with printer to print out the individual values, the means from the plates for each concentration together with standard deviations and enhancement factors as compared to the spontaneous reversion rates (see tables of results). Due to extensive bacterial growth the colonies were partly counted manually. - Evaluation criteria:
- A test item is considered as a mutagen if a biologically relevant increase in the number of revertants exceeding the threshold of twice (strains TA 98, TA 100, and TA102) or thrice (strains TA 1535 and TA 1537) the colony count of the corresponding solvent control is observed.
A dose dependent increase is considered biologically relevant if the threshold is exceeded at more than one concentration.
An increase exceeding the threshold at only one concentration is judged as biologically relevant if reproduced in an independent second experiment.
A dose dependent increase in the number of revertant colonies below the threshold is regarded as an indication of a mutagenic potential if reproduced in an independent second experiment. However, whenever the colony counts remain within the historical range of negative and solvent controls such an increase is not considered biologically relevant. - Statistics:
- According to the OECD guideline 471, a statistical analysis of the data is not mandatory.
Results and discussion
Test resultsopen allclose all
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- A single minor toxic effect, evident as a reduction in the number of revertants (below the indication factor of 0.5), was observed in experiment I in strain TA 98 with S9 mix at 5000 µg/plate.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- This study was performed to investigate the potential of 2,2-Dimethylthiazolidin to induce gene mutations according to the plate incorporation test (experiment I) and the pre-incubation test (experiment II) using the Salmonella typhimurium strains TA 1535, TA 1537, TA 98, TA 100, and TA102.
The assay was performed with and without liver microsomal activation. Each concentration, including the controls, was tested in triplicate. The test item was tested at the following concentrations:
Pre-Experiment/Experiment I: 3; 10; 33; 100; 333; 1000; 2500; and 5000 µg/plate
Experiment II: 33; 100; 333; 1000; 2500; and 5000 µg/plate
No precipitation of the test item occurred up to the highest investigated dose.
The plates incubated with the test item showed normal background growth up to 5000 µg/plate with and without S9 mix in all strains used.
No toxic effects other than the minor event mentioned in strain TA 98 occurred in the remaining test groups neither with nor without metabolic activation.
No substantial increase in revertant colony numbers of any of the five tester strains was observed following treatment with 2,2-Dimethylthiazolidin at any dose level, neither in the presence nor absence of metabolic activation (S9 mix). There was also no tendency of higher mutation rates with increasing concentrations in the range below the generally acknowledged border of biological relevance.
Appropriate reference mutagens were used as positive controls. They showed a distinct in-crease in induced revertant colonies. In experiment I, the data in the solvent control of strain TA 102 with S9 mix were slightly above our historical control range. Since this deviation is rather small (653 colonies vs. 652 colonies), this effect is considered to be biologically irrelevant.
Analytical Control
To demonstrate that the test system was exposed to the intended concentrations of the test item in the mutagenicity test, the concentrations of the test item in solution were determined by GC. The analysis was performed with all concentrations, which were obtained by serial dilution of the highest concentration used. The values found by analysis were in agreement with the intended concentrations (recovery rate: 100 % ± 20 %), in general.
The test item concentrations of the samples 4 and 7 in experiment I (nominal concentration: 1.00 and 25 mg/mL, respectively) and samples 2 and 3 in experiment II (nominal concentrations: 1.00 and 3.33 mg/mL, respectively) deviated more than 20 % from the nominal concentrations of these samples. However, the values of the stock solutions were within the acceptance range of the indicated nominal value. Since all concentrations were obtained by serial dilution of the stock solution in DMSO, this deviation from the theoretical values to the measured values had no influence on the results of this study. Furthermore the deviations are considered as irrelevant since all of the affected concentrations are in the non-toxic concentration range.
Any other information on results incl. tables
Summary of Experiment I
Study Name: 1810101 |
Study Code: Envigo 1810101 |
Experiment: 1810101 VVb |
Date Plated: 18.07.2017 |
Assay Conditions: |
Date Counted: 21.07.2017 |
Metabolic Activation |
Test Group |
Dose Level (per plate) |
Revertant Colony Counts (Mean ±SD) |
||||
|
|
|
|
|
|
|
|
|
|
|
TA 1535 |
TA 1537 |
TA 98 |
TA 100 |
TA 102 |
|
|
|
|
|
|
|
|
Without Activation |
DMSO |
|
10 ± 1 |
8 ± 2 |
24 ± 2 |
153 ± 34 |
527 ± 4 |
Untreated |
|
11 ± 1 |
8 ± 2 |
22 ± 3 |
176 ± 4 |
564 ± 37 |
|
2,2- Dimethyl- |
3 µg |
8 ± 3 |
8 ± 2 |
28 ± 7 |
157 ± 13 |
565 ± 31 |
|
thiazolidin |
10 µg |
8 ± 2 |
8 ± 2 |
21 ± 7 |
159 ± 16 |
554 ± 41 |
|
|
33 µg |
12 ± 4 |
9 ± 3 |
24 ± 3 |
154 ± 11 |
527 ± 11 |
|
|
100 µg |
7 ± 3 |
10 ± 2 |
24 ± 3 |
145 ± 9 |
554 ± 7 |
|
|
333 µg |
8 ± 3 |
9 ± 2 |
26 ± 4 |
164 ± 19 |
581 ± 50 |
|
|
1000 µg |
8 ± 2 |
11 ± 5 |
25 ± 4 |
146 ± 6 |
549 ± 20 |
|
|
2500 µg |
8 ± 3 |
6 ± 3 |
29 ± 5 |
150 ± 4 |
480 ± 31 |
|
|
5000 µg |
7 ± 2 |
7 ± 2 |
23 ± 4 |
152 ± 13 |
448 ± 10 |
|
NaN3 |
10 µg |
1111 ± 102 |
|
|
1743 ± 37 |
|
|
4-NOPD |
10 µg |
|
|
276 ± 17 |
|
|
|
4-NOPD |
50 µg |
|
87 ± 4 |
|
|
|
|
MMS |
2.0 µL |
|
|
|
|
3618 ± 192 |
|
|
|
|
|
|
|
|
|
With Activation |
DMSO |
|
9 ± 2 |
12 ± 4 |
47 ± 2 |
141 ± 6 |
653 ± 13 |
Untreated |
|
10 ± 5 |
10 ± 1 |
33 ± 14 |
156 ± 21 |
675 ± 7 |
|
2,2- Dimethyl- |
3 µg |
9 ± 2 |
13 ± 5 |
36 ± 11 |
127 ± 6 |
668 ± 31 |
|
thiazolidin |
10 µg |
6 ± 2 |
11 ± 5 |
36 ± 6 |
139 ± 18 |
641 ± 36 |
|
|
33 µg |
9 ± 2 |
12 ± 3 |
33 ± 9 |
129 ± 10 |
597 ± 24 |
|
|
100 µg |
13 ± 6 |
13 ± 3 |
26 ± 2 |
118 ± 3 |
598 ± 42 |
|
|
333 µg |
10 ± 3 |
10 ± 3 |
37 ± 8 |
112 ± 16 |
683 ± 28 |
|
|
1000 µg |
8 ± 3 |
15 ± 1 |
29 ± 2 |
147 ± 8 |
589 ± 20 |
|
|
2500 µg |
9 ± 3 |
9 ± 3 |
25 ± 9 |
133 ± 20 |
509 ± 23 |
|
|
5000 µg |
8 ± 2 |
6 ± 1 |
21 ± 5 |
136 ± 13 |
447 ± 38 |
|
2-AA |
2.5 µg |
384 ± 61 |
109 ± 6 |
3775 ± 45 |
2194 ± 559 |
|
|
2-AA |
10.0 µg |
|
|
|
|
1637 ± 110 |
|
|
|
|
|
|
|
|
|
Key to Positive Controls |
|
|
|
NaN3 2-AA MMS 4-NOPD |
sodium azide 2-aminoanthracene methyl methane sulfonate 4-nitro-o-phenylene-diamine |
Summary of Experiment II
Study Name: 1810101 |
Study Code: Envigo 1810101 |
Experiment: 1810101 HV2 Pre |
Date Plated: 05.09.2017 |
Assay Conditions: |
Date Counted: 11.09.2017 |
Metabolic Activation |
Test Group |
Dose Level (per plate) |
Revertant Colony Counts (Mean ±SD) |
||||
|
|
|
|
|
|
|
|
|
|
|
TA 1535 |
TA 1537 |
TA 98 |
TA 100 |
TA 102 |
|
|
|
|
|
|
|
|
Without Activation |
DMSO |
|
12 ± 5 |
10 ± 4 |
26 ± 6 |
127 ± 7 |
479 ± 17 |
Untreated |
|
11 ± 2 |
9 ± 1 |
34 ± 3 |
173 ± 27 |
501 ± 35 |
|
2,2- Dimethyl- |
33 µg |
11 ± 1 |
7 ± 2 |
30 ± 3 |
118 ± 4 |
491 ± 8 |
|
thiazolidin |
100 µg |
8 ± 3 |
8 ± 2 |
29 ± 4 |
120 ± 19 |
460 ± 20 |
|
|
333 µg |
10 ± 3 |
11 ± 0 |
29 ± 1 |
123 ± 10 |
437 ± 25 |
|
|
1000 µg |
11 ± 2 |
10 ± 1 |
26 ± 1 |
118 ± 16 |
431 ± 25 |
|
|
2500 µg |
12 ± 3 |
7 ± 3 |
25 ± 3 |
111 ± 5 |
434 ± 47 |
|
|
5000 µg |
13 ± 2 |
10 ± 1 |
21 ± 5 |
101 ± 6 |
482 ± 65 |
|
NaN3 |
10 µg |
1080 ± 49 |
|
|
2002 ± 95 |
|
|
4-NOPD |
10 µg |
|
|
1444 ± 24 |
|
|
|
4-NOPD |
50 µg |
|
86 ± 4 |
|
|
|
|
MMS |
2.0 µL |
|
|
|
|
4154 ± 182 |
|
|
|
|
|
|
|
|
|
With Activation |
DMSO |
|
11 ± 4 |
12 ± 2 |
32 ± 6 |
131 ± 10 |
642 ± 31 |
Untreated |
|
16 ± 1 |
13 ± 3 |
43 ± 10 |
183 ± 16 |
648 ± 4 |
|
2,2- Dimethyl- |
33 µg |
10 ± 4 |
12 ± 3 |
38 ± 11 |
145 ± 8 |
634 ± 24 |
|
thiazolidin |
100 µg |
12 ± 2 |
13 ± 3 |
42 ± 11 |
134 ± 17 |
622 ± 24 |
|
|
333 µg |
9 ± 3 |
16 ± 4 |
44 ± 7 |
114 ± 14 |
594 ± 4 |
|
|
1000 µg |
13 ± 3 |
16 ± 6 |
30 ± 9 |
134 ± 13 |
556 ± 45 |
|
|
2500 µg |
13 ± 5 |
6 ± 1 |
35 ± 6 |
121 ± 9 |
462 ± 35 |
|
|
5000 µg |
13 ± 5 |
6 ± 2 |
33 ± 10 |
106 ± 9 |
483 ± 25 |
|
2-AA |
2.5 µg |
386 ± 8 |
91 ± 17 |
3724 ± 338 |
2931 ± 207 |
|
|
2-AA |
10.0 µg |
|
|
|
|
1910 ± 84 |
|
|
|
|
|
|
|
|
|
Key to Positive Controls |
|
|
|
NaN3 2-AA MMS 4-NOPD |
sodium azide 2-aminoanthracene methyl methane sulfonate 4-nitro-o-phenylene-diamine |
Applicant's summary and conclusion
- Conclusions:
- In conclusion, it can be stated that during the described mutagenicity test and under the experimental conditions reported, the test item did not induce gene mutations by base pair changes or frameshifts in the genome of the strains used.
- Executive summary:
Summary
This study was performed to investigate the potential of 2,2-Dimethylthiazolidin to induce gene mutations according to the plate incorporation test (experiment I) and the pre-incubation test (experiment II) using the Salmonella typhimurium strains TA 1535, TA 1537, TA 98, TA 100, and TA102.
The assay was performed with and without liver microsomal activation. Each concentration, including the controls, was tested in triplicate. The test item was tested at the following concentrations:
Pre-Experiment/Experiment I: 3; 10; 33; 100; 333; 1000; 2500; and 5000 µg/plate
Experiment II: 33; 100; 333; 1000; 2500; and 5000 µg/plate
No precipitation of the test item occurred up to the highest investigated dose.
The plates incubated with the test item showed normal background growth up to 5000 µg/plate with and without S9 mix in all strains used.
A single minor toxic effect, evident as a reduction in the number of revertants (below the indication factor of 0.5), was observed in experiment I in strain TA 98 with S9 mix at 5000 µg/plate. No other toxic effects occurred in the remaining test groups neither with nor without metabolic activation.
No substantial increase in revertant colony numbers of any of the five tester strains was observed following treatment with 2,2-Dimethylthiazolidin at any dose level, neither in the presence nor absence of metabolic activation (S9 mix). There was also no tendency of higher mutation rates with increasing concentrations in the range below the generally acknowledged border of biological relevance.
Appropriate reference mutagens were used as positive controls and showed a distinct increase of induced revertant colonies.
Conclusion
In conclusion, it can be stated that during the described mutagenicity test and under the experimental conditions reported, the test item did not induce gene mutations by base pair changes or frameshifts in the genome of the strains used.
Therefore, 2,2-Dimethylthiazolidin is considered to be non-mutagenic in this Salmonella typhimurium reverse mutation assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.